{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:27:26Z","timestamp":1777523246607,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Advancing a Healthier Wisconsin"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.lungcan.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T19:25:53Z","timestamp":1436988353000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls"],"prefix":"10.1016","volume":"90","author":[{"given":"Shu","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiang-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Dittmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiezheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul","family":"Suster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.","family":"Mackinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2015.07.002_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2015.07.002_bib0010","unstructured":"Howlader N NA, Krapcho M, et al. SEER Cancer Statistics Review In: National Cancer Institute. vol. 1975-2009 (Vintage 2009 Populations) based on November 2011 SEER data submission, 1975-2009 (Vintage 2009 Populations) based on November 2011 SEER data submission. edn: Bethesda, MD; 2012."},{"key":"10.1016\/j.lungcan.2015.07.002_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2466-12-77","article-title":"Improving lung cancer survival; time to move on","volume":"12","author":"Heuvers","year":"2012","journal-title":"BMC Pulm. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2015.07.002_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","article-title":"Overdiagnosis in low-dose computed tomography screening for lung cancer","volume":"174","author":"Patz","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2015.07.002_bib0030","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1097\/JTO.0b013e3182a476d4","article-title":"Overdiagnosis in lung cancer screening with low-dose computed tomography","volume":"8","author":"Takiguchi","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.07.002_bib0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrm2858","article-title":"Genomic instability\u2013an evolving hallmark of cancer","volume":"11","author":"Negrini","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5969","key":"10.1016\/j.lungcan.2015.07.002_bib0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.327.5969.1074","article-title":"Keeping tabs on tumor DNA","volume":"327","author":"Kaiser Medicine","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lungcan.2015.07.002_bib0045","doi-asserted-by":"crossref","first-page":"e38559","DOI":"10.1371\/journal.pone.0038559","article-title":"Circulating DNA diagnostic tool and predictive marker for overall survival of NSCLC patients","volume":"7","author":"Catarino","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lungcan.2009.06.021","article-title":"Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer","volume":"68","author":"van der Drift","year":"2010","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/JTO.0b013e31820189a5","article-title":"Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer","volume":"6","author":"Sirera","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.lungcan.2015.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"7447","key":"10.1016\/j.lungcan.2015.07.002_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"issue":"162","key":"10.1016\/j.lungcan.2015.07.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004742","article-title":"Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing","volume":"4","author":"Leary","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2015.07.002_bib0075","article-title":"Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"issue":"52","key":"10.1016\/j.lungcan.2015.07.002_bib0080","doi-asserted-by":"crossref","first-page":"21083","DOI":"10.1073\/pnas.1320659110","article-title":"Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients","volume":"110","author":"Ni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1101\/gr.123497.111","article-title":"Genomic analysis of circulating cell-free DNA infers breast cancer dormancy","volume":"22","author":"Shaw","year":"2012","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.lungcan.2015.07.002_bib0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/gm434","article-title":"Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med."},{"issue":"14","key":"10.1016\/j.lungcan.2015.07.002_bib0095","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-11-4037","article-title":"Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing","volume":"72","author":"Narayan","year":"2012","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.lungcan.2015.07.002_bib0100","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/pmic.200401245","article-title":"HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples","volume":"5","author":"Rai","year":"2005","journal-title":"Proteomics"},{"issue":"19","key":"10.1016\/j.lungcan.2015.07.002_bib0105","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1093\/nar\/gkn556","article-title":"Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms","volume":"36","author":"Diskin","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.lungcan.2015.07.002_bib0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/0008-5472.CAN-09-3513","article-title":"Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells","volume":"70","author":"Garcia-Olmo","year":"2010","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2015.07.002_bib0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.seminoncol.2012.05.013","article-title":"Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma","volume":"39","author":"Zhou","year":"2012","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.07.002_bib0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.28030","article-title":"Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer","volume":"133","author":"Heitzer","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2015.07.002_bib0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1373\/clinchem.2012.196014","article-title":"Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing","volume":"59","author":"Chan","year":"2013","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.lungcan.2015.07.002_bib0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng1416","article-title":"Detection of large-scale variation in the human genome","volume":"36","author":"Iafrate","year":"2004","journal-title":"Nat. Genet."},{"issue":"136","key":"10.1016\/j.lungcan.2015.07.002_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2015.07.002_bib0145","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/1078-0432.CCR-13-2933","article-title":"Detection of cancer DNA in plasma of patients with early-stage breast cancer","volume":"20","author":"Beaver","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.lungcan.2015.07.002_bib0150","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-13-2482","article-title":"Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA","volume":"20","author":"Oxnard","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"7404","key":"10.1016\/j.lungcan.2015.07.002_bib0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","article-title":"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers","volume":"486","author":"Diaz","year":"2012","journal-title":"Nature"},{"issue":"224","key":"10.1016\/j.lungcan.2015.07.002_bib0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2015.07.002_bib0165","doi-asserted-by":"crossref","first-page":"e47020","DOI":"10.1371\/journal.pone.0047020","article-title":"Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers","volume":"7","author":"Perkins","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lungcan.2015.07.002_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1373\/clinchem.2012.196014","article-title":"Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing","volume":"59","author":"Chan","year":"2013","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.lungcan.2015.07.002_bib0175","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T04:28:38Z","timestamp":1566966518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0169500215300088"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.07.002","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}